R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

In a new episode, Simon Kohl discusses Latent Labs’ emergence from stealth, as well as protein design and drug discovery acceleration in more detail.

R&D

Sigma Mostafa, CSO at KBI BioPharma, discusses the role of CDMOs and the important factors companies should consider when selecting one.

R&D

With demand for cell and gene therapies (CGTs) growing rapidly, blood centres are indispensable collaborators.

R&D

Shawn Hodges, CEO of Revelation Pharma, discusses the true state of drug shortages in the US at the moment and the role of compounding pharmacies.

R&D

Today, the demand for speed, quality, and scalability is pushing the industry towards a different model: integrated manufacturing.

R&D

Sandeep Kulkarni, CEO of Tourmaline Bio, discusses inflammation, & the impact of AI and GLP-1s on cardiology clinical trials and drug development.